Last edition
News about
CordenPharma, GENEPEP Celebrate Strong Alliance for Developing Peptide Drug Substance
CordenPharma and GENEPEP have recently celebrated one year of their fruitful collaboration.
FDA Approves GenFleet's GFH925 Phase III Trial for Colorectal Cancer
The primary objective is to compare the efficacy of GFH925 versus the current standard of care.
Nora Pharma Gets Health Canada Approval for Commercializing NIOPEG
Nora Pharma has received approval for its first Biosimilar product.
Cochlear Limited Expands Access to Osia System for Children as Young as 5
The Osia System is a new category of bone conduction hearing solutions that uses digital piezoelectric stimulation to bypass damaged areas of the natural hearing system to send sound vibrations directly to the inner ear (cochlea).
Dr. Reddys Laboratories Unveils DailyBloom IBS Program to Manage IBS
Dr. Reddy’s Laboratories Ltd. has introduced its condition management program DailyBloom IBS, an integrated care plan for Irritable Bowel Syndrome (IBS).
BioCryst Announces Approval of ORLADEYO from Brazilian Health Regulatory Agency
BioCryst Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval for oral, once-daily ORLADEYO (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults.
ENTOD Pharma Gets CDSCO Approval for PresVu to Treat Age-Related Vision Impairment
ENTOD Pharmaceuticals has gained approval from the Central Drugs Standard Control Organisation (CDSCO) for PresVu to treat age-related vision impairment.
Scopio Labs Receives FDA Clearance for Full-Field Bone Marrow Aspirate Application
This clearance establishes a new regulatory category for all-digital bone marrow aspirate analysis software, heralding a transformative era in hematologic diagnostics.
Jubilant Generics Limited's Roorkee Facility Receives VAI Classification from USFDA
This classification signifies that the facility is deemed to be in an acceptable state of compliance with current good manufacturing practices (cGMP).
CDSCO Issues Guidelines to Curb Circulation of Substandard Pharmaceuticals
Central Drugs Standard Control Organisation (CDSCO) has recently issued draft guidelines on good distribution practices to curb the introduction of spurious, adulterated and sub-standard pharmaceutical products in the market.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy